Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2022 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering

MINNEAPOLIS, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage company focused on transforming the lives of people with fluid...
October 03, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting

MINNEAPOLIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the results...
September 27, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial

MINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the...
August 31, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces New Clinical Data Demonstrating 100% Survival at 30 Days Following Use of Ultrafiltration in High-Risk Postoperative Coronary Artery Bypass Grafting (CABG) Patients

MINNEAPOLIS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the...
August 25, 2022 07:00 ET | Source: Nuwellis, Inc.

U.S. Patent and Trademark Office Awards Nuwellis Patent for Innovative Pediatric Technology

MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a commercial stage company dedicated to transforming the lives of patients suffering from fluid overload, today announced...
August 19, 2022 15:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MINNEAPOLIS, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective August 18, 2022, the independent directors approved equity awards under Nuwellis’ 2021...
August 19, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis Inc. to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

MINNEAPOLIS, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase,...
August 09, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Announces Second Quarter 2022 Financial Results

MINNEAPOLIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2022, which included the following highlights: ...
July 26, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA

MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced the...
July 14, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022

MINNEAPOLIS, July 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its second quarter 2022 financial results will be released on Tuesday, August 9, 2022. The company...